Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study

BACKGROUND: Clinical trials have shown that erenumab is effective and well-tolerated for the preventive treatment of chronic migraine. To extend the results from clinical trials, we assessed the real-world efficacy and safety of erenumab in patients with chronic migraine from the outpatient clinic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cullum, Christopher Kjaer, Do, Thien Phu, Ashina, Messoud, Bendtsen, Lars, Hugger, Sarah Sonja, Iljazi, Afrim, Gusatovic, Julia, Snellman, Josefin, Lopez-Lopez, Cristina, Ashina, Håkan, Amin, Faisal Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164431/
https://www.ncbi.nlm.nih.gov/pubmed/35655137
http://dx.doi.org/10.1186/s10194-022-01433-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164431/
https://www.ncbi.nlm.nih.gov/pubmed/35655137
http://dx.doi.org/10.1186/s10194-022-01433-9

Ejemplares similares